|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INTEGRATIVE |
Departments of
1 Internal Medicine
2 Anaesthesiology, Mayo Clinic College of Medicine, Rochester, MN55905, USA
The ß2-adrenergic receptors (ß2ARs) play a role in renal Na+ regulation. Subjects homozygous for glycine at amino acid 16 (Gly16) of the ß2AR have been shown to have enhanced ß2-mediated vascular relaxation when compared to subjects homozygous for arginine (Arg16). However, Gly16 subjects have been shown to have higher blood pressure than Arg16 subjects. Given the dominant role of the kidneys in long-term blood pressure regulation, we sought to determine whether there were differences in renal Na+ handling between Gly16 (n
= 17) and Arg16 (n
= 14) subjects (Gly16: age, 30 ± 2 years; body mass index (BMI), 25 ± 11 kg m2; Arg16: age, 30 ± 2 years; BMI, 25 ± 1 kg m2). We measured urinary Na+ content before and for 3 h following rapid intravenous saline infusion (30 ml kg1 in
16 min). Prior to the infusion, there were no differences in 24-h Na+ excretion between Gly16 and Arg16 subjects (Gly16, 183 ± 21 mmol; Arg16, 184 ± 20 mmol); however, systolic blood pressure (SBP) was significantly higher in Gly16 than Arg16 subjects with no differences observed in diastolic blood pressure (DBP) or mean arterial pressure (MAP) (SBP: Gly16, 117 ± 3 mmHg; Arg16, 109 ± 2 mmHg; DBP: Gly16, 78 ± 2 mmHg; Arg16, 77 ± 2 mmHg; MAP: Gly16, 90 ± 2 mmHg; Arg16, 89 ± 2 mmHg). With rapid saline infusion, MAP increased in both genotype groups (Gly16, 6.7%; Arg16, 3.4%; P > 0.05). In the 3 h following Na+ infusion, Na+ excretion was less in Gly16 when compared to Arg16 subjects, with a trend towards significance when expressed as total Na+ excreted (Gly16, 66 ± 7 mmol; Arg16, 85 ± 9 mmol; P
= 0.07), and a significant difference when expressed as a fraction of the administered load (Gly16, 0.18 ± 0.02; Arg16, 0.28 ± 0.03; P < 0.01). These results suggest that the Arg16Gly polymorphism of the ß2AR is associated with differences in natriuretic response to rapid saline infusion, which may influence long-term regulation of blood pressure.
(Received 16 February 2006;
accepted after revision 17 May 2006;
first published online 25 May 2006)
Corresponding author E. M. Snyder: Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 1st Street, SW Rochester, MN 55905, USA. Email: snyder.eric{at}mayo.edu
This article has been cited by other articles:
![]() |
E. M. Snyder, K. C. Beck, S. T. Turner, E. A. Hoffman, M. J. Joyner, and B. D. Johnson Genetic variation of the beta2-adrenergic receptor is associated with differences in lung fluid accumulation in humans J Appl Physiol, June 1, 2007; 102(6): 2172 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Eisenach, D. R. Schroeder, T. L. Pike, C. P. Johnson, W. G. Schrage, E. M. Snyder, B. D. Johnson, V. D. Garovic, S. T. Turner, and M. J. Joyner Dietary sodium restriction and {beta}2-adrenergic receptor polymorphism modulate cardiovascular function in humans J. Physiol., August 1, 2006; 574(3): 955 - 965. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |